ONC

BeOne Medicines Ltd Sponsored ADR · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website -
Employees(FY) -
ISIN US07725L1026

Performance

+0.51%

+21.52%

+8.44%

+42.29%

+20.93%

YTD

+50.69%

Profile

Advanced Technical Analysis

Technical Analysis of ONC 2025-02-03

The stock exhibits a strong bullish sentiment with a Moving Average Score of 83 and a Technical Score of 75, indicating positive momentum and trend strength. However, the Oscillators Score of 43 suggests a neutral stance, implying potential caution in the short term despite the overall bullish outlook.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ONC

Stock Rank

Recent News & Updates

2024-11-12 11:12
Decoding BeiGene Ltd (BGNE): A Strategic SWOT Insight(Yahoo Finance)
2024-11-11 17:00
BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates(Businesswire)
2024-11-05 17:01
BeiGene to Present at the Jefferies London Healthcare Conference(Businesswire)
2024-11-04 20:05
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024(Businesswire)
2024-10-27 18:00
BeiGene Mourns Death of Beloved Board Member Donald Glazer(Businesswire)
2024-10-20 18:00
BeiGene Receives Positive CHMP Opinions for TEVIMBRA as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma(Businesswire)
2024-10-15 18:00
BeiGene Highlights Waldenstrms Macroglobulinemia Innovation at IWWM 2024(Businesswire)
2024-10-09 22:09
Heres Why BeiGene, Ltd. (BGNE) Rallied in Q3(Yahoo Finance)
2024-10-06 17:04
BeiGene (BGNE) Moves 5.3% Higher: Will This Strength Last?(Yahoo Finance)
2024-10-03 21:00
FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket(Prnewswire)
2024-09-26 06:21
BeiGene Provides Update on FDA Advisory Committee Vote on Benefit-Risk Profile of PD-1 Inhibitors, including TEVIMBRA, for Treatment of ESCC and Gastric/GEJ Cancers(Businesswire)
2024-09-25 18:00
Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors(Businesswire)
2024-09-25 03:54
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients(Yahoo Finance)
2024-09-17 16:12
BeiGenes TEVIMBRA gains approval for OSCC in Israel(Yahoo Finance)
2024-09-16 19:00
BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy(Businesswire)
2024-09-12 09:00
BeiGene Singapore Raises Awareness for World Lymphoma Awareness Day 2024: It's Time for Honest Talk(Yahoo Finance)
2024-09-08 19:00
BeiGene Announces Updates to Commercial Leadership Team(Businesswire)
2024-09-08 13:00
BeiGene Highlights TEVIMBRA Data in Lung and Gastrointestinal Cancers at ESMO 2024(Businesswire)
2024-08-27 21:55
Wall Street Analysts See a 27.84% Upside in BeiGene (BGNE): Can the Stock Really Move This High?(Yahoo Finance)
2024-08-27 18:01
BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference(Businesswire)
2024-08-26 20:23
FDA grants fast track status to BeiGenes BGB-16673 for CLL/SLL(Yahoo Finance)
2024-08-25 21:55
BeiGene, Ltd. (BGNE) Just Flashed Golden Cross Signal: Do You Buy?(Yahoo Finance)
2024-08-25 18:00
BeiGenes BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL(Businesswire)
2024-08-23 02:10
Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting PD-1 Drugs For Stomach Cancer(Yahoo Finance)
2024-08-11 21:55
Wall Street Analysts See a 40.85% Upside in BeiGene (BGNE): Can the Stock Really Move This High?(Yahoo Finance)
2024-08-07 13:05
Beyond the Balance Sheet: What SWOT Reveals About BeiGene Ltd (BGNE)(Yahoo Finance)
2024-08-06 18:00
BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates(Businesswire)
2024-07-31 16:12
NICE recommends BeiGenes MZL tablet for NHS use(Yahoo Finance)
2024-07-23 18:33
BeiGene opens biologics facility in New Jersey, US(Yahoo Finance)
2024-07-22 19:00
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World(Businesswire)

Page 2 of 4

previous next

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.